🧬 Rafael Rosengarten - Part 2 | From Marine Biology to Synthetic Biology | Building Biofuel Tools at JBEI | When Academic Labs Embrace Entrepreneurship
Part 2 of 4: My guest today is Rafael Rosengarten, CEO and Co-Founder of Genialis, the RNA biomarker company. Genialis is reimagining biomarkers for every target, drug, and patient using a combination of precision oncology, RNA, and AI.
Rafael, a biomedical research veteran, combines academic excellence with industry innovation. A Dartmouth graduate with a Yale doctorate, he conducted postdoctoral research at Lawrence Berkeley National Laboratory, where he co-invented the j5 DNA assembly tool. As co-founder of the Alliance for AI in Healthcare, he advocates for responsible AI integration in medicine, drawing from his extensive background in evolution, immunology, bioengineering, and genetics.
🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success.
🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸
🔗 Get your unique referral link here:
refer.excedr.com/ZTHETY.
Part 2 of 4: My guest today is Rafael Rosengarten, CEO and Co-Founder of Genialis, the RNA biomarker company. Genialis is reimagining biomarkers for every target, drug, and patient using a combination of precision oncology, RNA, and AI.
Rafael, a biomedical research veteran, combines academic excellence with industry innovation. A Dartmouth graduate with a Yale doctorate, he conducted postdoctoral research at Lawrence Berkeley National Laboratory, where he co-invented the j5 DNA assembly tool. As co-founder of the Alliance for AI in Healthcare, he advocates for responsible AI integration in medicine, drawing from his extensive background in evolution, immunology, bioengineering, and genetics.
In this episode, you'll hear about:
- Rafael's graduate studies at Yale, where mentors fostered his independent research approach
- His diverse marine biology and genomics projects, preparing him for synthetic biology
- Rafael's transition to the Joint BioEnergy Institute (JBEI) for synthetic biology and biofuels research
- The collaborative environment at JBEI, including access to cutting-edge technology and bioinformatics tool development
- Rafael's insights on choosing the right lab environment and the growing acceptance of entrepreneurship in academia
If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening!
Find Our Guest, Rafael Rosengarten, at these links:
Find Our Host, Jon Chee, at these links:
Excedr Socials & Website
Enriched Notes:
Topics Mentioned:
What Should Investors & Founders Expect From Each Other
People Mentioned:
Timestamps:
00:00 - Intro
02:56 - Rafael's experience with his graduate advisors and diverse research projects
07:45 - Comparison of grad school experience to company building and board members
08:59 - Discussion about Jonathan Rothberg and sequencing developments at Yale
10:06 - Rafael's transition from Yale to the Joint BioEnergy Institute (JBEI)
12:46 - The importance of showing up and making connections in person
16:39 - The value of face-to-face interactions in business and collaboration
20:19 - Challenges in the biotech market and the need for in-person networking
23:11 - Rafael's work at JBEI in synthetic biology and tool development
28:22 - Key takeaways from Rafael's experience at JBEI
30:25 - The importance of entrepreneurship in academia and industry
33:55 - Outro